* Detection of Sars-Cov-2 with reverse transcption Real time PCR ( TAT 2.0 hr )
* Amplify N gene and RdRp(orf1ab) gene of Sars-Cov2
AVAILABLE SAMPLE TYPE
* Sputum
* Oropharyngeal ( OP ) and nasopharyngeal ( NP ) swabs
Ezplex Respiratory Pathogens Real-time PCR Kit is an in vitro diagnostic test for the qualitative detection of 19 respiratory viruses and 6 types of pneumonia-causing bacteria through nucleic acids isolated and extracted from human throat swabs using real-time polymerase chain reaction
Comprehensive Panel- One test can identify 19 respiratory viruses and 6 bacterial species simultaneously.
Sensitivity Detection of all targeted viruses and bacteria with high sensitivity.
Convenience Genetree Viewer analysis software available for users to conveniently produce test results.
Clinical Performance: Clinical testing confirmed the high sensitivity and specificity.
Stability: Shelf life of up to 12 months.
Analytical Specificity: Testing of 31 species of microorganisms showed no cross reactivity.
SFTS Virus Real-time PCR Kit is an in vitro diagnostic test intended for the qualitative detection of the Dabie bandavirus that causes Severe Fever with thrombocytopenia Syndrome using nucleic acid RNA extracted from human blood or serum. Clinical evaluation performed with human blood specimens confirmed clinical accuracy. High reproducibility with similar results were confirmed various tests.
Ezplex MTBC/NTM Real-time PCR Kit is an in vitro diagnostic test that simultaneously detects Mycobacterium tuberculosis complex (MTBC) and 20 types of nontuberculous mycobacteria (NTM).
Sensitivity : Multiple gene targets for MTBC and NTM.
Clinical Performance: Validated clinical performance.
Fast Results: Testing can be completed within 2 hours post extraction.
Helicobacter pylori is a parasitic bacterium in the stomach that lives between the gastric mucosa and mucus. According to the WHO, more than half of the world's population has H. pylori and is the third leading cause of cancer-related deaths. In 1994, the WHO's IARC classified H. Pylori as a Class 1 carcinogen. The incidence of H. pylori in developing countries is the highest worldwide, highlighting the need for highly accurate and manageable testing. By 2025, the H. pylori testing market is expected to be worth 6 billion. Accordingly, SML Genetree has developed a reagent that can diagnose Helico-bacter pylori and Clarithromycin-resistant mutants (A2142G, A2143G) through DNA extracted from human hygienic tissue using Real-time Polymerase Chain Reaction. Since it contains multiple gene regions, Helico-bacter pylori and Clarithromycin-resistant mutations can be detected sensitively, and high reproducibility has been demonstrated through repeated tests by serially diluting various positive samples and standards. In addition, as a result of clinical evaluation on human sanitary inspection tissue by commissioning a large domestic consignment inspection institution, high sensitivity and specificity were confirmed, proving its excellent clinical performance.
